At the time of writing, Compass Therapeutics Inc [CMPX] stock is trading at $4.28, up 1.06%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CMPX shares have gain 16.76% over the last week, with a monthly amount glided 20.03%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Leerink Partners upgraded its rating to Outperform on April 02, 2025, and kept the price target unchanged to $6. On February 24, 2025, Guggenheim initiated with a Buy rating and assigned a price target of $12 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $12 on February 19, 2025. D. Boral Capital initiated its recommendation with a Buy and recommended $32 as its price target on December 23, 2024. Leerink Partners downgraded its rating to Market Perform for this stock on November 15, 2024, and downed its price target to $4. In a note dated September 16, 2024, Ladenburg Thalmann upgraded an Buy rating on this stock but restated the target price of $5.
For the past year, the stock price of Compass Therapeutics Inc fluctuated between $1.27 and $4.31. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Compass Therapeutics Inc [NASDAQ: CMPX] shares were valued at $4.28 at the most recent close of the market. An investor can expect a potential return of 133.64% based on the average CMPX price forecast.
Analyzing the CMPX fundamentals
According to Compass Therapeutics Inc [NASDAQ:CMPX], the company’s sales were 0.00M for trailing twelve months, which represents an -100.00% plunge. To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.53 and Total Capital is -0.66. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Compass Therapeutics Inc [NASDAQ:CMPX] has a current ratio of 7.66. Also, the Quick Ratio is 7.66, while the Cash Ratio stands at 1.65.
Transactions by insiders
Recent insider trading involved Schuetz Thomas J., CHIEF EXECUTIVE OFFICER, that happened on May 27 ’25 when 10000.0 shares were purchased. Director, GORDON CARL L completed a deal on Apr 09 ’25 to sell 3.57 million shares. Meanwhile, Director ORBIMED ADVISORS LLC sold 3.57 million shares on Apr 09 ’25.
